Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

Jan 17, 2018, 09:00 ET Aeon Global Health Announces Exclusive Marketing and Sales Agreement for Trusted Branded Pharmaceutical

Aeon Global Health, the operating arm of Authentidate Holding Corp. (OTCQB: ADAT), a growth-oriented provider of personalized, clinically...


Jan 17, 2018, 09:00 ET Neurim Pharmaceuticals' New Paediatric Prolonged-Release Melatonin ("PedPRM") to Be Marketed by BIOCODEX Oy in Finland

Neurim Pharmaceuticals ('Neurim') and BIOCODEX Oy ('Biocodex') announced today a license agreement in which Biocodex will obtain the exclusive...


Jan 17, 2018, 09:00 ET Lyric Pharma Granted FDA Fast Track Designation for Lead Product Ulimorelin for Enteral Feeding Intolerance (EFI)

Lyric Pharmaceuticals, Inc (Lyric), a biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has...


Jan 17, 2018, 08:30 ET Standout Canadian Players Foster 'the Cannabis Lifestyle'

Canada's impending legalization of recreational marijuana has triggered a surge in investment activity as investors lean toward Canadian companies...


Jan 17, 2018, 08:30 ET Corporate Whistleblower Center Urges MDs, Hospital DBDs or Employees to Call Them About Potential Significant Rewards if Their Employer is Bribing Physicians for Patient Admissions

The Corporate Whistleblower Center says, "Hospitals bribing or providing incentives to physicians for admissions should not come as a surprise to...


Jan 17, 2018, 08:30 ET CVS Health Launches New Transform Rheumatoid Arthritis Care™ Program to Improve Clinical Outcomes and Lower Pharmacy Costs

CVS Health (NYSE: CVS) today introduced Transform Rheumatoid Arthritis Care™ to help the company's pharmacy benefit management (PBM) clients better...


Jan 17, 2018, 08:30 ET US Drug Watchdog Now Urges Persons Who Used the Type Two Diabetes Drug Invokana and Suffered Kidney Failure or a Below the Knee Amputation to Call Them About Possible Significant Compensation

The US Drug Watchdog fears that some users of the type two diabetes drug called Invokana may have developed kidney failure or a below the knee...


Jan 17, 2018, 08:10 ET OBI Pharma annonce que la FDA a approuvé une demande d'IND pour une étude de phase 1 d'immunothérapie du cancer par anticorps monoclonaux (OBI-888)

Premiers essais cliniques pour tester l'innocuité et l'activité préliminaire de l'immunothérapie passive reposant sur des anticorps monoclonaux...


Jan 17, 2018, 08:00 ET MIHI Launches a New Health Care Sharing Organization (HCSO) Designed for 58 Million US-based Hispanics Requiring Coverage

Medical Innovation Holdings, Inc. ("MIHI" or the "Company") (OTC: MIHI) today announces the launch of a Health Care Sharing Organization (HCSO) to...


Jan 17, 2018, 08:00 ET Bayer to Highlight New Research at ASCO GI 2018 Cancer Symposium

Bayer announced today that new data from the continued research on Stivarga® (regorafenib) and Nexavar® (sorafenib) in advanced liver, colorectal...


Jan 17, 2018, 08:00 ET Relmada Therapeutics Acquires Global Rights to Develop and Market Dextromethadone for Treatment of Disorders of the Nervous System

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS)...


Jan 17, 2018, 08:00 ET AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M West 2018

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes...


Jan 17, 2018, 07:30 ET konectar KOL Management Platform - Next Generation Cloud Application for Medical Thought Leader Management

Aissel Technologies, Inc., announces the launch of their new product, konectar. konectar is a highly advanced medical KOL Management Platform...


Jan 17, 2018, 07:05 ET RXi Pharmaceuticals to Present at Immuno-Oncology Frontiers World Conference

RXi Pharmaceuticals Corporation (NASDAQ: RXII) a clinical-stage company developing a new class of RNAi-based therapeutics today announced that it...


Jan 17, 2018, 07:00 ET Liquid Biopsy Performance Comparison of OncoBEAM RAS CRC and Idylla ctKRAS Testing Presented at ASCO GI 2018 Meeting

Sysmex Inostics, a global leader in blood based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, today announces...


Jan 17, 2018, 07:00 ET Super Savings: Inside Rx Expands Its Prescription Savings Program, Offers Discounts on 100 Brand Name Medications

Inside Rx announced today the addition of 30 new brand-name prescription medications to its featured medications list, bringing the total number of...


Jan 17, 2018, 07:00 ET BioLineRx Announces Partial Monotherapy Results from Phase 2a COMBAT Study in Pancreatic Cancer

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today partial...


Jan 17, 2018, 06:45 ET This Morning's Technical Outlook on Generic Drugs Stocks -- Versartis, Diplomat Pharmacy, Mallinckrodt, and Zoetis

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on VSAR, DPLO, MNK, and ZTS...


Jan 17, 2018, 06:15 ET Free Research Reports on These Biotech Stocks -- Spectrum Pharma, Teligent, Vertex Pharma, and VIVUS

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on SPPI, TLGT, VRTX, and...


Jan 17, 2018, 06:00 ET Outpost Medicine Announces Acceptance of Two Investigational New Drug Applications for OP-687 by U.S. FDA

Outpost Medicine, a biopharmaceutical company focused on the development of new treatments of urologic and gastrointestinal disorders, today...


Jan 17, 2018, 06:00 ET Global Oligonucleotide Synthesis Market to Reach US$ 770 Mn by 2025 - Persistence Market Research

Oligonucleotides are short fragments of nucleic acids and play a major role in drug discovery and molecular diagnostic chip technology....


Jan 17, 2018, 05:18 ET Active Pharmaceutical Ingredients (API) Market to Represent a Value of USD 239.8 Billion With CAGR Of 6.0% by 2025 | Million Insights

The global Active Pharmaceutical Ingredient (API) market size was worth at USD 134.2 billion in the year 2015 which is anticipated to reach a...


Jan 17, 2018, 05:00 ET OBI Pharma Announces FDA Clearance Of IND Application For A Phase 1 Study Of A Monoclonal Antibody Cancer Immunotherapy (OBI-888).

OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has cleared an...


Jan 17, 2018, 01:00 ET Pharming Announces FDA Acceptance for Review of Supplemental Biologics License Application for RUCONEST® for Prophylaxis of Hereditary Angioedema Attacks

Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announced today that the U.S. Food and Drug Administration (FDA) has...


Jan 16, 2018, 21:40 ET ESSA expects 180-day extension to regain compliance with the Nasdaq Bid Price Rule

HOUSTON and VANCOUVER, Jan. 16, 2018 /PRNewswire/ - ESSA Pharma Inc. (TSXV: EPI; Nasdaq: EPIX) ("ESSA" or the "Company") announced today that it...